These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9063490)
1. [Chemosensitivity test for gastric carcinoma]. Kubota T Gan To Kagaku Ryoho; 1997 Feb; 24(4):495-500. PubMed ID: 9063490 [TBL] [Abstract][Full Text] [Related]
2. Potential of the histoculture drug-response assay to contribute to cancer patient survival. Kubota T; Sasano N; Abe O; Nakao I; Kawamura E; Saito T; Endo M; Kimura K; Demura H; Sasano H Clin Cancer Res; 1995 Dec; 1(12):1537-43. PubMed ID: 9815954 [TBL] [Abstract][Full Text] [Related]
3. Clinical applications of the histoculture drug response assay. Furukawa T; Kubota T; Hoffman RM Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986 [TBL] [Abstract][Full Text] [Related]
4. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay. Tanino H; Oura S; Hoffman RM; Kubota T; Furukawa T; Arimoto J; Yoshimasu T; Hirai I; Bessho T; Suzuma T; Sakurai T; Naito Y Anticancer Res; 2001; 21(6A):4083-6. PubMed ID: 11911296 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer. Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide. Ohie S; Udagawa Y; Kozu A; Komuro Y; Aoki D; Nozawa S; Moossa AR; Hoffman RM Anticancer Res; 2000; 20(3B):2049-54. PubMed ID: 10928150 [TBL] [Abstract][Full Text] [Related]
7. Chemosensitivity of breast cancer lymph node metastasis compared to the primary tumor from individual patients tested in the histoculture drug response assay. Furukawa T; Kubota T; Tanino H; Oura S; Yuasa S; Murate H; Morita K; Kozakai K; Yano T; Hoffman RM Anticancer Res; 2000; 20(5C):3657-8. PubMed ID: 11268434 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the histoculture drug response assay as a sensitivity test for anticancer agents. Suda S; Akiyama S; Sekiguchi H; Kasai Y; Ito K; Nakao A Surg Today; 2002; 32(6):477-81. PubMed ID: 12107769 [TBL] [Abstract][Full Text] [Related]
9. Chemosensitivity testing of primary tumor cells from gastric cancer patients with liver metastasis can identify effective antitumor drugs. Kurihara N; Kubota T; Furukawa T; Watanabe M; Otani Y; Kumai K; Kitajima M Anticancer Res; 1999; 19(6B):5155-8. PubMed ID: 10697526 [TBL] [Abstract][Full Text] [Related]
10. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer. Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475 [TBL] [Abstract][Full Text] [Related]
11. Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation. Noso Y; Niimi K; Nishiyama M; Hirabayashi N; Toge T; Niimoto M; Hattori T Cancer Res; 1987 Dec; 47(23):6418-22. PubMed ID: 3677085 [TBL] [Abstract][Full Text] [Related]
12. The measurement of glucose consumption in histoculture to determine effects of doxorubicin and cisplatinum on human gastric carcinoma. Chang SG; Chai SE; Kim ES; Yoon C; Joo HZ; Hoffman RM Anticancer Res; 1993; 13(5A):1303-10. PubMed ID: 8239500 [TBL] [Abstract][Full Text] [Related]
13. Prospective Clinical Correlation of the Histoculture Drug Response Assay for Ovarian Cancer. Hoffman RM; Jung PS; Kim MB; Nam JH Methods Mol Biol; 2018; 1760():73-81. PubMed ID: 29572795 [TBL] [Abstract][Full Text] [Related]
14. Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assay. Nio Y; Tamura K; Kan N; Inamoto T; Ohgaki K; Kodama H Anticancer Res; 2000; 20(2B):1237-44. PubMed ID: 10810427 [TBL] [Abstract][Full Text] [Related]
15. Clinical Correlation of the Histoculture Drug Response Assay for Head and Neck Cancer. Hoffman RM Methods Mol Biol; 2018; 1760():83-92. PubMed ID: 29572796 [TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of serum p53 antibody detection in a chemosensitivity assay in cases of human colorectal cancer]. Takeda A; Shimada H; Nakajima K; Imaseki H; Okazumi S; Takayama W; Iwasaki K; Makino H; Natsume T; Kouno T; Kondo S; Suzuki T; Ochiai T; Isono K Gan To Kagaku Ryoho; 2000 Jun; 27(6):879-83. PubMed ID: 10897215 [TBL] [Abstract][Full Text] [Related]
17. Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma. Hasegawa Y; Goto M; Hanai N; Ijichi K; Terada A; Hyodo I; Ogawa T; Fukushima M Oncology; 2007; 73(1-2):104-11. PubMed ID: 18337622 [TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of chemotherapy based on an in vitro chemosensitivity test in urothelial cancer patients. Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K Anticancer Res; 2001; 21(6A):4061-6. PubMed ID: 11911292 [TBL] [Abstract][Full Text] [Related]
19. A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer. Cree IA; Kurbacher CM; Lamont A; Hindley AC; Love S; Anticancer Drugs; 2007 Oct; 18(9):1093-101. PubMed ID: 17704660 [TBL] [Abstract][Full Text] [Related]
20. Clinical Correlation of the Histoculture Drug Response Assay in Gastrointestinal Cancer. Hoffman RM Methods Mol Biol; 2018; 1760():61-72. PubMed ID: 29572794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]